0001179110-21-010830.txt : 20211210 0001179110-21-010830.hdr.sgml : 20211210 20211210170205 ACCESSION NUMBER: 0001179110-21-010830 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211209 FILED AS OF DATE: 20211210 DATE AS OF CHANGE: 20211210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GONZALEZ RICHARD A CENTRAL INDEX KEY: 0001239127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 211486097 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2021-12-09 0 0001551152 AbbVie Inc. ABBV 0001239127 GONZALEZ RICHARD A 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 1 1 0 0 Chairman of the Board and CEO Common Stock, $0.01 par value 2021-12-09 4 M 0 174100 61.36 A 550697 D Common Stock, $0.01 par value 2021-12-09 4 S 0 64476 122.8012 D 486221 D Common Stock, $0.01 par value 2021-12-09 4 S 0 109624 123.4758 D 376597 D Common Stock, $0.01 par value 17615 I By Spouse Common Stock, $0.01 par value 5900 I By Step-daughter Common Stock, $0.01 par value 5900 I By Step-son Option (Right To Buy) 0 2021-12-09 4 M 0 174100 61.36 D 2018-02-16 2027-02-15 Common Stock 174100 87050 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.19 to $123.18 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.19 to $123.48 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person disclaims beneficial ownership of these securities. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Richard A. Gonzalez 2021-12-10